Claire Paquet

10.8k total citations · 2 hit papers
177 papers, 4.4k citations indexed

About

Claire Paquet is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Claire Paquet has authored 177 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Physiology, 70 papers in Psychiatry and Mental health and 40 papers in Molecular Biology. Recurrent topics in Claire Paquet's work include Alzheimer's disease research and treatments (91 papers), Dementia and Cognitive Impairment Research (68 papers) and Neuroinflammation and Neurodegeneration Mechanisms (14 papers). Claire Paquet is often cited by papers focused on Alzheimer's disease research and treatments (91 papers), Dementia and Cognitive Impairment Research (68 papers) and Neuroinflammation and Neurodegeneration Mechanisms (14 papers). Claire Paquet collaborates with scholars based in France, United Kingdom and United States. Claire Paquet's co-authors include Jacques Hugon, Julien Dumurgier, François Mouton‐Liger, Françoise Gray, Jean Laplanche, Henrik Zetterberg, Paul Dighiero, Roger Gil, Kaj Blennow and M Boissonnot and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Claire Paquet

164 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of sleep duration in middle and old age with incidence of dementia

2021 370 citations Sèverine Sabia, Julien Dumurgier et al. profile →
Les professionnels de santé face à la pandémie de la maladie à coronavirus (COVID-19) : quels risques pour leur santé mentale ?

2020 315 citations Claire Paquet, Djamila Bennabi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claire Paquet France	34	1.8k	1.0k	1.0k	707	686	177	4.4k
Heather M. Snyder United States	23	1.5k 0.8×	771 0.7×	1.4k 1.4×	720 1.0×	898 1.3×	67	4.5k
Cláudia Kimie Suemoto Brazil	35	1.6k 0.9×	739 0.7×	1.2k 1.2×	819 1.2×	462 0.7×	258	4.7k
Gerwyn Morris Australia	49	1.5k 0.8×	1.5k 1.4×	1.5k 1.5×	492 0.7×	731 1.1×	103	8.5k
Hiroyuki Umegaki Japan	39	1.6k 0.8×	905 0.9×	967 0.9×	599 0.8×	340 0.5×	229	5.1k
Walter Swardfager Canada	40	1.8k 1.0×	1.1k 1.1×	1.4k 1.3×	1.8k 2.6×	435 0.6×	166	8.7k
Michal Schnaider Beeri United States	42	2.2k 1.2×	705 0.7×	2.1k 2.0×	911 1.3×	319 0.5×	237	6.1k
Seol‐Heui Han South Korea	38	1.6k 0.9×	1.1k 1.1×	1.3k 1.3×	1.0k 1.5×	408 0.6×	185	5.5k
Robert Perry United Kingdom	36	1.3k 0.7×	1.3k 1.2×	1.2k 1.2×	841 1.2×	1.2k 1.8×	75	4.8k
Michelle Gee United Kingdom	17	1.7k 0.9×	763 0.7×	1.3k 1.3×	504 0.7×	260 0.4×	26	3.8k

Countries citing papers authored by Claire Paquet

Since Specialization

Citations

This map shows the geographic impact of Claire Paquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Paquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Paquet more than expected).

Fields of papers citing papers by Claire Paquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Paquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Paquet. The network helps show where Claire Paquet may publish in the future.

Co-authorship network of co-authors of Claire Paquet

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Paquet. A scholar is included among the top collaborators of Claire Paquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Paquet. Claire Paquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tovar, Diego, Francisco Lopera, David Aguillón, et al.. (2025). Characterizing resting-state EEG oscillatory and aperiodic activity in neurodegenerative diseases: A multicentric study. Computers in Biology and Medicine. 197(Pt B). 111080–111080. 1 indexed citations

Pujol, Claire, et al.. (2025). Non-canonical STAT3 pathway induces alterations of mitochondrial dynamic proteins in the hippocampus of an LPS-induced murine neuroinflammation model. Neurochemistry International. 186. 105979–105979. 2 indexed citations

Vrillon, Agathe, Nicholas J. Ashton, Élodie Bouaziz-Amar, et al.. (2025). Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disorders. EBioMedicine. 115. 105694–105694. 3 indexed citations

Gaubert, Sinead, Pilar Garcés, Joerg F. Hipp, et al.. (2025). Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer's disease dementia. EBioMedicine. 114. 105659–105659.

Dumurgier, Julien, Claire Paquet, Jacques Hugon, et al.. (2025). MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study. The Journal of Prevention of Alzheimer s Disease. 12(3). 100077–100077.

Galvin, James E., Jeffrey L. Cummings, Carl de Moor, et al.. (2024). Generating real‐world evidence in Alzheimer's disease: Considerations for establishing a core dataset. Alzheimer s & Dementia. 20(6). 4331–4341. 5 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Luc Buée, et al.. (2024). Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease. Molecular Neurodegeneration. 19(1). 66–66. 8 indexed citations

Dumurgier, Julien, et al.. (2024). Brain 18FDG-PET pattern in cognitively impaired elderly patients with bipolar disorder. International Journal of Bipolar Disorders. 12(1). 45–45. 1 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2024). Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment. Journal of Neurology Neurosurgery & Psychiatry. 95(11). 1046–1053. 20 indexed citations

10.

Vrillon, Agathe, Olivier Bousiges, Catherine Demuynck, et al.. (2024). Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies. Alzheimer s Research & Therapy. 16(1). 146–146. 8 indexed citations

11.

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function. Journal of Neurology Neurosurgery & Psychiatry. 94(6). 411–419. 32 indexed citations

12.

Grasset, Leslie, Vincent Planche, Vincent Bouteloup, et al.. (2023). Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort. Alzheimer s & Dementia. 19(12). 5700–5718. 7 indexed citations

13.

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia. Clinical Chemistry. 69(9). 1072–1083. 4 indexed citations

14.

Camporesi, Elena, Johanna Nilsson, Agathe Vrillon, et al.. (2022). Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry. EBioMedicine. 75. 103793–103793. 5 indexed citations

15.

Cognat, Emmanuel, Philippe Michaud, Éric Hispard, et al.. (2022). Patients With Severe Alcohol-Related Cognitive Impairment Improve in Flexibility When Abstinence Is Maintained: A Comparative Study With Alzheimer’s Disease. Frontiers in Psychology. 13. 936639–936639. 5 indexed citations

16.

Queneau, Mathieu, M. Rodallec, Brigitte Landeau, et al.. (2021). Brain Glucose Metabolism in Cerebral Amyloid Angiopathy. Stroke. 52(4). 1478–1482. 5 indexed citations

17.

Leroy, Mélanie, Émilie Olié, Éloi Magnin, et al.. (2021). Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort. Journal of Personalized Medicine. 11(11). 1183–1183. 8 indexed citations

18.

Lilamand, Matthieu, Claire Hourrègue, & Claire Paquet. (2020). Interest of biological biomarkers in the diagnostic approach of neurocognitive disorders in the elderly. Revue Neurologique. 176(9). 677–683. 9 indexed citations

19.

Paquet, Claire, James A. R. Nicoll, Seth Love, et al.. (2017). Downregulated apoptosis and autophagy after anti‐Aβ immunotherapy in Alzheimer's disease. Brain Pathology. 28(5). 603–610. 30 indexed citations

20.

Mouton‐Liger, François, David Wallon, Anne‐Cécile Troussière, et al.. (2013). Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study. Journal of Neurology. 261(1). 144–151. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact